AmitDesaiMD
Cardiology • Boston, MAAdult Congenital Heart Disease, Heart Failure & Transplantation
Assistant Professor of Medicine, Brigham and Women's Hospital
Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Brigham And Women's Hospital Cardiovascular Division
Boston, MA 02115Phone+1 857-307-4000
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2001 - 2004
Harvard Medical SchoolClass of 1998
Certifications & Licensure
MA State Medical License 2000 - 2025
ME State Medical License 2011 - 2019- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Ventricular-Vascular Coupling in Heart Failure Start of enrollment: 2004 Jan 01
Publications & Presentations
PubMed
- 4154 citationsAngiotensin-neprilysin inhibition versus enalapril in heart failure.John J.V. McMurray, Milton Packer, Akshay S. Desai, Jianjian Gong, Martin Lefkowitz
The New England Journal of Medicine. 2014-09-10 - 523 citationsSpironolactone for heart failure with preserved ejection fraction.Bertram Pitt, Marc A Pfeffer, Susan F Assmann, Robin Boineau, Inder S Anand
The New England Journal of Medicine. 2014-04-10 - 1 citationsDuration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial.John W Ostrominski, Brian L Claggett, Milton Packer, Marc A Pfeffer, Carolyn S P Lam
Journal of Cardiac Failure. 2023-11-01
Journal Articles
- Remote Optimization of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection FractionAkshay S Desai, Thomas Gaziano, Benjamin Scirica, Calum A Macrae, JAMA Cardiology
- Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients with Heart Failure with and Without DiabetesAkshay S Desai, Mikhail N Kosiborod, Marc S Sabatine, JAMA
- Navigator-Driven Remote Optimization of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: Program Design and Initial Fe...Thomas A Gaziano, Calum A Macrae, Benjamin M Scirica, Akshay S Desai, Journal of Cardiac Failure
- Join now to see all
Lectures
- Setting up an Ambulatory Hemodynamic Clinic:The Essentials2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Test Your Knowledge: Heart Failure and Arrhythmias2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Best of ACC.13: Take Home Messages for the Clinician (Boston)American College of Cardiology Foundation, Boston, Massachusetts - 4/26/2013
- Join now to see all
Authored Content
- Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart FailureApril 2020
- Navigator-Driven Remote Optimization of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: Program Design and Initial FeasibilityAugust 2018
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?November 13th, 2024- Finerenone in Patients with a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial | JACC | HFSA 2024October 4th, 2024
- FINEARTS-HF: New Analyses Ask, Who Benefits Most from Finerenone?October 2nd, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
